pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›VORICONAZOLE
drug
save

VORICONAZOLE

Marketedupdated 3mo ago
by United Biomedical Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 6
  • tagApproval358 co-mentions · 179 sources
  • drugVfend312 co-mentions · 183 sources
  • tagSmall Molecule130 co-mentions · 130 sources
  • companyAjanta Pharma Ltd11 co-mentions · 11 sources
  • companyGlenmark Pharmaceuticals Ltd6 co-mentions · 2 sources
  • tagRecall6 co-mentions · 4 sources

all catalysts(30)

approval · 30
May 24, 2016
approval
10y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
May 24, 2016
approval
10y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 8, 2019
approval
7y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 8, 2019
approval
7y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 9, 2019
approval
7y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 9, 2019
approval
7y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 9, 2019
approval
7y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 9, 2019
approval
7y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Mar 15, 2021
approval
5y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Mar 15, 2021
approval
5y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Mar 15, 2021
approval
5y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 16, 2021
approval
5y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 16, 2021
approval
5y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jul 16, 2021
approval
5y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
May 9, 2022
approval
4y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jun 13, 2022
approval
4y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jun 13, 2022
approval
4y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jun 13, 2022
approval
4y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jun 13, 2022
approval
4y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Jun 13, 2022
approval
4y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Nov 29, 2022
approval
4y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Nov 29, 2022
approval
4y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Feb 2, 2023
approval
4y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Feb 2, 2023
approval
4y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Aug 8, 2023
approval
3y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Aug 8, 2023
approval
3y ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Sep 26, 2025
approval
11mo ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Sep 30, 2025
approval
11mo ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Oct 23, 2025
approval
10mo ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
Nov 14, 2025
approval
9mo ago
VORICONAZOLE — FDA approval
VORICONAZOLE
→
view all 30 catalysts →

Trials studying VORICONAZOLE

  • phase1Study on the Drug Interaction Between Buagafuran and Voriconazolenot yet recruitingn=18
  • phase1A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participantscompletedn=32
  • phase1Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignanciesterminatedn=46
  • phase3Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosiscompletedn=527
  • phase3Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infectionscompletedn=450
  • phase2Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemiacompletedn=265
  • phase1Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levelsterminatedn=18
  • —Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosisno longer available
more trials →

News(0)

no news has mentioned this drug yet

brand
VORICONAZOLE
generic
VORICONAZOLE
indication
Aspergillosis
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 32m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?